Table 3 Main trial characteristics of RCTs including majority of older people
2012 | 2019 | ||
|---|---|---|---|
(N = 300) | (N = 363) | ||
Number of participants, N (median IQR) | 114 (47–288) | 104 (58–240) | |
Age of participants, years (median, IQR) | 66 (63–70) | 66 (63–70) | |
Disease categories, N (%) | |||
Circulatory | 74 (25) | Circulatory | 75 (21) |
Neoplasms | 56 (19) | Neoplasms | 66 (18) |
Musculoskeletal | 28 (9) | Musculoskeletal | 51(14) |
Nervous | 13 (8) | Metabolic | 30 (8) |
Digestive | 19 (6) | Respiratory | 24 (7) |
Other | 100 (33) | Other | 117 (32) |